12:00 AM
 | 
Jul 20, 2009
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Medivation, Pfizer preclinical data

Researchers at Mount Sinai School of Medicine and colleagues reported that acute treatment with Dimebon increased levels of beta amyloid in mouse models of AD. The researchers said the results, which were presented at...

Read the full 158 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >